1. Emerging roles of Nrf2 signal in non-small cell lung cancer
    Yijun Tian et al, 2016, Journal of Hematology & Oncology CrossRef
  2. Nrf2 at the heart of oxidative stress and cardiac protection
    Qin M. Chen et al, 2018, Physiological Genomics CrossRef
  3. Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
    Qingsong Wang et al, 2020, PLOS ONE CrossRef
  4. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
    Morana Jaganjac et al, 2020, Antioxidants CrossRef
  5. The complexity of the Nrf2 pathway: beyond the antioxidant response
    Ying Huang et al, 2015, The Journal of Nutritional Biochemistry CrossRef
  6. The role of Nrf2 transcription factor in viral infection
    Ali Ramezani et al, 2018, Journal of Cellular Biochemistry CrossRef
  7. Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses
    L Torrente et al, 2017, Oncogene CrossRef
  8. Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer
    Sinong Jia et al, 2021, Frontiers in Genetics CrossRef
  9. Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database
    Yanyu Wu et al, 2022, Clinical Lung Cancer CrossRef
  10. The antioxidant response in Barrett's tumorigenesis: A double-edged sword
    Dunfa Peng et al, 2021, Redox Biology CrossRef
  11. Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer
    Jinfeng Liu et al, 2024, Global Medical Genetics CrossRef
  12. Functional polymorphisms in Nrf2: implications for human disease
    Hye-Youn Cho et al, 2015, Free Radical Biology and Medicine CrossRef
  13. The Keap1-Nrf2 Signaling Pathway in Lung Cancer
    Azhwar Raghunath et al, 2021, Targeting Cellular Signalling Pathways in Lung Diseases CrossRef
  14. Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment
    Maria Russo et al, 2018, Critical Reviews in Food Science and Nutrition CrossRef
  15. Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
    Deepika Sirohi et al, 2020, The Journal of Molecular Diagnostics CrossRef
  16. Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models
    Hye-Youn Cho et al, 2015, Archives of Toxicology CrossRef
  17. High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro
    Laura Torrente et al, 2020, Biomolecules CrossRef
  18. Identification of novel Nrf2/Keap1 pathway mutations in pediatric acute lymphoblastic leukemia
    Dilara Fatma Akın-Balı et al, 2020, Pediatric Hematology and Oncology CrossRef
  19. Mitochondria, cholesterol and cancer cell metabolism
    Vicent Ribas et al, 2016, Clinical and Translational Medicine CrossRef
  20. Squamous Carcinoma of the Lung: Still a Long and Winding Road to Successful Treatment
    Paolo Bironzo et al, 2014, Lung Cancer Management CrossRef
  21. Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study
    Tomoya Kawaguchi et al, 2016, Journal of Clinical Oncology CrossRef